
C
Tier
GH-releasing peptide with very strong appetite stimulation.
Muscle & Performance
Peptide
WADA Status:
Prohibited at all times (S2)
Human Trial Scoreboard
Completed human RCTs
Count not verified
Largest Human Study
Size not verified
Longest exposure
Duration not verified
Most Recent Trial
Year not verified
Description
GHRP-6 is one of the earliest growth hormone releasing peptides and works through the ghrelin receptor. Its most consistent, reproducible and well documented effect is a substantial increase in hunger, which follows logically from mimicking the hormone your body releases when your stomach is empty. This is rarely the headline in marketing material, where it is presented as a lean-mass compound. The growth hormone release it produces is real and measurable, but no completed trial has shown that this translates into meaningful changes in muscle, fat or performance. It was investigated decades ago, never approved for consumer use, and now circulates as a research chemical.
What Are The Claims
Claims made for this compound: Stimulates GH release; Strong appetite stimulation, sometimes used during bulking or poor appetite; Proposed recovery effects
Evidence
Same picture as GHRP-2: demonstrated GH release, marked appetite stimulation, no outcome trials.
Evidence Strength
Preliminary (small human GH-release data)
Caveats
Not approved; stimulates appetite, cortisol and prolactin; no clinical-outcome trials.
Safety
Alternative Measures
Legal Status
US
Not approved
UK
Not approved
EU
Not approved
AU
Not approved
WADA
Prohibited at all times (S2)
Not approved. Research chemical. WADA-prohibited.
Citations
Bowers et al. human GH-release studies (1990s).